本文呼籲合併使用支持性療法及臨床試驗才是唯一找出治療武漢肺炎及未來類似流行病安全且有效的方法。

(財團法人國家衛生研究院 莊淑鈞博士摘要整理)

In the 2014 Ebola outbreak, close to 30 000 individuals developed Ebola viral disease (EVD), and numerous therapies were tested against this virus, including chloroquine, hydroxychloroquine, favipiravir, brincidofovir, monoclonal antibodies, antisense RNA, and convalescent plasma, among many others. With such a large number of therapeutic interventions given to affected patients, the goal was to determine which was efficacious against Ebola. Ultimately, none proved to be efficacious or safe.

Author:Andre C Kalil
原文連結:https://jamanetwork.com/journals/jama/fullarticle/2763802